FDA
approval
· 2022-02-25
FDA Approved: TRIAMTERENE AND HYDROCHLOROTHIAZIDE — Supplemental Application (BluePoint Laboratories)
Summary
The FDA approved a supplemental application for the generic combination Triamterene and Hydrochlorothiazide from BluePoint Laboratories. The product is a diuret…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for TRIAMTERENE AND HYDROCHLOROTHIAZIDE (TRIAMTERENE AND HYDROCHLOROTHIAZIDE)